-
1
-
-
79151478658
-
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
-
10.1016/S0140-6736(10)62231-3, 3018568, 21183212, ICBP Module 1 Working Group
-
Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA, . ICBP Module 1 Working Group Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011, 377(9760):127-38. 10.1016/S0140-6736(10)62231-3, 3018568, 21183212, ICBP Module 1 Working Group.
-
(2011)
Lancet
, vol.377
, Issue.9760
, pp. 127-138
-
-
Coleman, M.P.1
Forman, D.2
Bryant, H.3
Butler, J.4
Rachet, B.5
Maringe, C.6
Nur, U.7
Tracey, E.8
Coory, M.9
Hatcher, J.10
McGahan, C.E.11
Turner, D.12
Marrett, L.13
Gjerstorff, M.L.14
Johannesen, T.B.15
Adolfsson, J.16
Lambe, M.17
Lawrence, G.18
Meechan, D.19
Morris, E.J.20
Middleton, R.21
Steward, J.22
Richards, M.A.23
more..
-
2
-
-
79961091216
-
Anti-tumour activity of bisphosphonates in preclinical models of breast cancer
-
10.1186/bcr2769, 3046431, 21176176
-
Holen I, Coleman RE. Anti-tumour activity of bisphosphonates in preclinical models of breast cancer. Breast Cancer Res 2010, 12(6):214. 10.1186/bcr2769, 3046431, 21176176.
-
(2010)
Breast Cancer Res
, vol.12
, Issue.6
, pp. 214
-
-
Holen, I.1
Coleman, R.E.2
-
3
-
-
68949114117
-
Tumor-associated macrophages: effectors of angiogenesis and tumor progression
-
Coffelt SB, Hughes R, Lewis CE. Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 2009, 1796(1):11-8.
-
(2009)
Biochim Biophys Acta
, vol.1796
, Issue.1
, pp. 11-18
-
-
Coffelt, S.B.1
Hughes, R.2
Lewis, C.E.3
-
4
-
-
77950588300
-
Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors
-
10.2353/ajpath.2010.090786, 2843445, 20167863
-
Coffelt SB, Lewis CE, Naldini L, Brown JM, Ferrara N, De Palma M. Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol 2010, 176(4):1564-76. 10.2353/ajpath.2010.090786, 2843445, 20167863.
-
(2010)
Am J Pathol
, vol.176
, Issue.4
, pp. 1564-1576
-
-
Coffelt, S.B.1
Lewis, C.E.2
Naldini, L.3
Brown, J.M.4
Ferrara, N.5
De Palma, M.6
-
5
-
-
40049088602
-
The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages
-
10.1016/j.critrevonc.2007.07.004, 17913510
-
Allavena P, Sica A, Solinas G, Porta C, Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008, 66(1):1-9. 10.1016/j.critrevonc.2007.07.004, 17913510.
-
(2008)
Crit Rev Oncol Hematol
, vol.66
, Issue.1
, pp. 1-9
-
-
Allavena, P.1
Sica, A.2
Solinas, G.3
Porta, C.4
Mantovani, A.5
-
6
-
-
31544441610
-
Distinct role of macrophages in different tumor microenvironments
-
10.1158/0008-5472.CAN-05-4005, 16423985
-
Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006, 66(2):605-12. 10.1158/0008-5472.CAN-05-4005, 16423985.
-
(2006)
Cancer Res
, vol.66
, Issue.2
, pp. 605-612
-
-
Lewis, C.E.1
Pollard, J.W.2
-
7
-
-
63149160727
-
Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB
-
10.1182/blood-2008-12-172825, 2869029, 19171876
-
Hagemann T, Biswas SK, Lawrence T, Sica A, Lewis CE. Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. Blood 2009, 113(14):3139-46. 10.1182/blood-2008-12-172825, 2869029, 19171876.
-
(2009)
Blood
, vol.113
, Issue.14
, pp. 3139-3146
-
-
Hagemann, T.1
Biswas, S.K.2
Lawrence, T.3
Sica, A.4
Lewis, C.E.5
-
8
-
-
33645991795
-
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy
-
10.1016/j.ejca.2006.01.003, 16520032
-
Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006, 42(6):717-27. 10.1016/j.ejca.2006.01.003, 16520032.
-
(2006)
Eur J Cancer
, vol.42
, Issue.6
, pp. 717-727
-
-
Sica, A.1
Schioppa, T.2
Mantovani, A.3
Allavena, P.4
-
9
-
-
63049104211
-
Microenvironmental regulation of metastasis
-
10.1038/nrc2618, 19279573
-
Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9(4):239-52. 10.1038/nrc2618, 19279573.
-
(2009)
Nat Rev Cancer
, vol.9
, Issue.4
, pp. 239-252
-
-
Joyce, J.A.1
Pollard, J.W.2
-
10
-
-
33845767868
-
Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer
-
10.1158/0008-5472.CAN-06-1278, 17114237
-
Y LE. Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer. Cancer Res 2006, 66(23):11238-46. 10.1158/0008-5472.CAN-06-1278, 17114237.
-
(2006)
Cancer Res
, vol.66
, Issue.23
, pp. 11238-11246
-
-
Y, L.E.1
-
11
-
-
0035911221
-
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
-
10.1084/jem.193.6.727, 2193412, 11257139
-
Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001, 193(6):727-40. 10.1084/jem.193.6.727, 2193412, 11257139.
-
(2001)
J Exp Med
, vol.193
, Issue.6
, pp. 727-740
-
-
Lin, E.Y.1
Nguyen, A.V.2
Russell, R.G.3
Pollard, J.W.4
-
12
-
-
0033780453
-
Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas
-
10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G, 11004690
-
Lewis JS, Landers RJ, Underwood JC, Harris AL, Lewis CE. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 2000, 192(2):150-8. 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G, 11004690.
-
(2000)
J Pathol
, vol.192
, Issue.2
, pp. 150-158
-
-
Lewis, J.S.1
Landers, R.J.2
Underwood, J.C.3
Harris, A.L.4
Lewis, C.E.5
-
13
-
-
0033903714
-
Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer
-
Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000, 6(8):3282-9.
-
(2000)
Clin Cancer Res
, vol.6
, Issue.8
, pp. 3282-3289
-
-
Ueno, T.1
Toi, M.2
Saji, H.3
Muta, M.4
Bando, H.5
Kuroi, K.6
-
14
-
-
0005339099
-
Tumor-associated macrophages in breast cancer
-
10.1023/A:1020304003704, 12463738
-
Leek RD, Harris AL. Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 2002, 7(2):177-89. 10.1023/A:1020304003704, 12463738.
-
(2002)
J Mammary Gland Biol Neoplasia
, vol.7
, Issue.2
, pp. 177-189
-
-
Leek, R.D.1
Harris, A.L.2
-
15
-
-
3042749576
-
Role of infiltrated leucocytes in tumour growth and spread
-
10.1038/sj.bjc.6601705, 2410285, 15164120
-
Lin EY, Pollard JW. Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 2004, 90(11):2053-8. 10.1038/sj.bjc.6601705, 2410285, 15164120.
-
(2004)
Br J Cancer
, vol.90
, Issue.11
, pp. 2053-2058
-
-
Lin, E.Y.1
Pollard, J.W.2
-
16
-
-
33745258657
-
Tumor-driven evolution of immunosuppressive networks during malignant progression
-
10.1158/0008-5472.CAN-05-4128, 16740684
-
Kim R, Emi M, Tanabe K, Arihiro K. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res 2006, 66(11):5527-36. 10.1158/0008-5472.CAN-05-4128, 16740684.
-
(2006)
Cancer Res
, vol.66
, Issue.11
, pp. 5527-5536
-
-
Kim, R.1
Emi, M.2
Tanabe, K.3
Arihiro, K.4
-
17
-
-
33845466231
-
Monocyte/macrophage infiltration in tumors: modulators of angiogenesis
-
10.1189/jlb.0905495, 16997855
-
Dirkx AE, Oude Egbrink MG, Wagstaff J, Griffioen AW. Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J Leukoc Biol 2006, 80(6):1183-96. 10.1189/jlb.0905495, 16997855.
-
(2006)
J Leukoc Biol
, vol.80
, Issue.6
, pp. 1183-1196
-
-
Dirkx, A.E.1
Oude Egbrink, M.G.2
Wagstaff, J.3
Griffioen, A.W.4
-
18
-
-
0036187615
-
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
-
10.1002/path.1027, 11857487
-
Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002, 196(3):254-65. 10.1002/path.1027, 11857487.
-
(2002)
J Pathol
, vol.196
, Issue.3
, pp. 254-265
-
-
Bingle, L.1
Brown, N.J.2
Lewis, C.E.3
-
19
-
-
0029816609
-
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma
-
Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996, 56(20):4625-9.
-
(1996)
Cancer Res
, vol.56
, Issue.20
, pp. 4625-4629
-
-
Leek, R.D.1
Lewis, C.E.2
Whitehouse, R.3
Greenall, M.4
Clarke, J.5
Harris, A.L.6
-
20
-
-
67651146533
-
Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts
-
10.1158/1535-7163.MCT-09-0280, 19567820
-
Roland CL, Dineen SP, Lynn KD, Sullivan LA, Dellinger MT, Sadegh L, et al. Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts. Mol Cancer Ther 2009, 8(7):1761-71. 10.1158/1535-7163.MCT-09-0280, 19567820.
-
(2009)
Mol Cancer Ther
, vol.8
, Issue.7
, pp. 1761-1771
-
-
Roland, C.L.1
Dineen, S.P.2
Lynn, K.D.3
Sullivan, L.A.4
Dellinger, M.T.5
Sadegh, L.6
-
21
-
-
37049006066
-
Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma
-
10.1158/0008-5472.CAN-07-1882, 2646404, 18056472
-
Melani C, Sangaletti S, Barazzetta FM, Werb Z, Colombo MP. Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. Cancer Res 2007, 67(23):11438-46. 10.1158/0008-5472.CAN-07-1882, 2646404, 18056472.
-
(2007)
Cancer Res
, vol.67
, Issue.23
, pp. 11438-11446
-
-
Melani, C.1
Sangaletti, S.2
Barazzetta, F.M.3
Werb, Z.4
Colombo, M.P.5
-
22
-
-
4944244259
-
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues
-
10.1182/blood-2004-03-1109, 15231578
-
Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004, 104(8):2224-34. 10.1182/blood-2004-03-1109, 15231578.
-
(2004)
Blood
, vol.104
, Issue.8
, pp. 2224-2234
-
-
Murdoch, C.1
Giannoudis, A.2
Lewis, C.E.3
-
23
-
-
0036493984
-
Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer
-
Leek RD, Talks KL, Pezzella F, Turley H, Campo L, Brown NS, et al. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res 2002, 62(5):1326-9.
-
(2002)
Cancer Res
, vol.62
, Issue.5
, pp. 1326-1329
-
-
Leek, R.D.1
Talks, K.L.2
Pezzella, F.3
Turley, H.4
Campo, L.5
Brown, N.S.6
-
24
-
-
77955258493
-
Association of macrophages with angiogenesis in oral verrucous and squamous cell carcinomas
-
El-Rouby DH. Association of macrophages with angiogenesis in oral verrucous and squamous cell carcinomas. J Oral Pathol Med 2010, 39(7):559-64.
-
(2010)
J Oral Pathol Med
, vol.39
, Issue.7
, pp. 559-564
-
-
El-Rouby, D.H.1
-
25
-
-
0034650795
-
Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha
-
Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, et al. Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer. United States 2000, 85(2):182-8.
-
(2000)
Int J Cancer. United States
, vol.85
, Issue.2
, pp. 182-188
-
-
Torisu, H.1
Ono, M.2
Kiryu, H.3
Furue, M.4
Ohmoto, Y.5
Nakayama, J.6
-
26
-
-
0034143110
-
Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth
-
al-Sarireh B, Eremin O. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb 2000, 45(1):1-16.
-
(2000)
J R Coll Surg Edinb
, vol.45
, Issue.1
, pp. 1-16
-
-
al-Sarireh, B.1
Eremin, O.2
-
27
-
-
24744454660
-
Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density
-
Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 2005, 14(2):425-31.
-
(2005)
Oncol Rep
, vol.14
, Issue.2
, pp. 425-431
-
-
Tsutsui, S.1
Yasuda, K.2
Suzuki, K.3
Tahara, K.4
Higashi, H.5
Era, S.6
-
28
-
-
0028929409
-
Macrophage-like-cell-induced growth regulation of lymphoma cells
-
10.1159/000227457, 7715903
-
Komanduri KC, Tomes DJ, Gabius HJ, Joshi SS. Macrophage-like-cell-induced growth regulation of lymphoma cells. Oncology 1995, 52(3):196-201. 10.1159/000227457, 7715903.
-
(1995)
Oncology
, vol.52
, Issue.3
, pp. 196-201
-
-
Komanduri, K.C.1
Tomes, D.J.2
Gabius, H.J.3
Joshi, S.S.4
-
29
-
-
0018677342
-
Macrophages/monocytes require cell-to-cell contact in order to regulate the growth of a murine lymphoma cell line
-
Hewlett G, Opitz HG, Flad HD, Schlumberger HD. Macrophages/monocytes require cell-to-cell contact in order to regulate the growth of a murine lymphoma cell line. J Immunol 1979, 123(5):2265-9.
-
(1979)
J Immunol
, vol.123
, Issue.5
, pp. 2265-2269
-
-
Hewlett, G.1
Opitz, H.G.2
Flad, H.D.3
Schlumberger, H.D.4
-
30
-
-
0022643111
-
In vitro interactions of murine peritoneal macrophages and sarcoma cells. I. Promotion of tumor cells proliferation by macrophages
-
Plytycz B, Pedersen A, Bogwald J, Seljelid R. In vitro interactions of murine peritoneal macrophages and sarcoma cells. I. Promotion of tumor cells proliferation by macrophages. Virchows Arch B Cell Pathol Incl Mol Pathol 1986, 50(3):285-92.
-
(1986)
Virchows Arch B Cell Pathol Incl Mol Pathol
, vol.50
, Issue.3
, pp. 285-292
-
-
Plytycz, B.1
Pedersen, A.2
Bogwald, J.3
Seljelid, R.4
-
31
-
-
0027848681
-
Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration
-
Richter G, Kruger-Krasagakes S, Hein G, Huls C, Schmitt E, Diamantstein T, et al. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res 1993, 53(18):4134-7.
-
(1993)
Cancer Res
, vol.53
, Issue.18
, pp. 4134-4137
-
-
Richter, G.1
Kruger-Krasagakes, S.2
Hein, G.3
Huls, C.4
Schmitt, E.5
Diamantstein, T.6
-
32
-
-
71049140879
-
Delayed growth of EL4 lymphoma in SR-A-deficient mice is due to upregulation of nitric oxide and interferon-gamma production by tumor-associated macrophages
-
10.1111/j.1349-7006.2009.01296.x, 19694752
-
Komohara Y, Takemura K, Lei XF, Sakashita N, Harada M, Suzuki H, et al. Delayed growth of EL4 lymphoma in SR-A-deficient mice is due to upregulation of nitric oxide and interferon-gamma production by tumor-associated macrophages. Cancer Sci 2009, 100(11):2160-6. 10.1111/j.1349-7006.2009.01296.x, 19694752.
-
(2009)
Cancer Sci
, vol.100
, Issue.11
, pp. 2160-2166
-
-
Komohara, Y.1
Takemura, K.2
Lei, X.F.3
Sakashita, N.4
Harada, M.5
Suzuki, H.6
-
33
-
-
33644935220
-
Invadopodia and podosomes in tumor invasion
-
10.1016/j.ejcb.2005.10.004, 16546563
-
Yamaguchi H, Pixley F, Condeelis J. Invadopodia and podosomes in tumor invasion. Eur J Cell Biol 2006, 85(3-4):213-8. 10.1016/j.ejcb.2005.10.004, 16546563.
-
(2006)
Eur J Cell Biol
, vol.85
, Issue.3-4
, pp. 213-218
-
-
Yamaguchi, H.1
Pixley, F.2
Condeelis, J.3
-
34
-
-
31044433663
-
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis
-
10.1016/j.cell.2006.01.007, 16439202
-
Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124(2):263-6. 10.1016/j.cell.2006.01.007, 16439202.
-
(2006)
Cell
, vol.124
, Issue.2
, pp. 263-266
-
-
Condeelis, J.1
Pollard, J.W.2
-
35
-
-
4944229701
-
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors
-
10.1158/0008-5472.CAN-04-1449, 15466195
-
Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004, 64(19):7022-9. 10.1158/0008-5472.CAN-04-1449, 15466195.
-
(2004)
Cancer Res
, vol.64
, Issue.19
, pp. 7022-7029
-
-
Wyckoff, J.1
Wang, W.2
Lin, E.Y.3
Wang, Y.4
Pixley, F.5
Stanley, E.R.6
-
36
-
-
50849090319
-
Macrophages define the invasive microenvironment in breast cancer
-
10.1189/jlb.1107762, 2516896, 18467655
-
Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 2008, 84(3):623-30. 10.1189/jlb.1107762, 2516896, 18467655.
-
(2008)
J Leukoc Biol
, vol.84
, Issue.3
, pp. 623-630
-
-
Pollard, J.W.1
-
37
-
-
14744286895
-
Tumor cells caught in the act of invading: their strategy for enhanced cell motility
-
10.1016/j.tcb.2005.01.003, 15752977
-
Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE, Condeelis JS. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 2005, 15(3):138-45. 10.1016/j.tcb.2005.01.003, 15752977.
-
(2005)
Trends Cell Biol
, vol.15
, Issue.3
, pp. 138-145
-
-
Wang, W.1
Goswami, S.2
Sahai, E.3
Wyckoff, J.B.4
Segall, J.E.5
Condeelis, J.S.6
-
38
-
-
3342904989
-
Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases
-
10.1093/carcin/bgh146, 15044327
-
Hagemann T, Robinson SC, Schulz M, Trumper L, Balkwill FR, Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004, 25(8):1543-9. 10.1093/carcin/bgh146, 15044327.
-
(2004)
Carcinogenesis
, vol.25
, Issue.8
, pp. 1543-1549
-
-
Hagemann, T.1
Robinson, S.C.2
Schulz, M.3
Trumper, L.4
Balkwill, F.R.5
Binder, C.6
-
39
-
-
33845354896
-
Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland
-
10.1002/dvdy.20972, 17029292
-
Ingman WV, Wyckoff J, Gouon-Evans V, Condeelis J, Pollard JW. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn 2006, 235(12):3222-9. 10.1002/dvdy.20972, 17029292.
-
(2006)
Dev Dyn
, vol.235
, Issue.12
, pp. 3222-3229
-
-
Ingman, W.V.1
Wyckoff, J.2
Gouon-Evans, V.3
Condeelis, J.4
Pollard, J.W.5
-
40
-
-
26044442817
-
Macrophages direct tumour histology and clinical outcome in a colon cancer model
-
10.1002/path.1830, 16104052
-
Oosterling SJ, van der Bij GJ, Meijer GA, Tuk CW, van Garderen E, van Rooijen N, et al. Macrophages direct tumour histology and clinical outcome in a colon cancer model. J Pathol 2005, 207(2):147-55. 10.1002/path.1830, 16104052.
-
(2005)
J Pathol
, vol.207
, Issue.2
, pp. 147-155
-
-
Oosterling, S.J.1
van der Bij, G.J.2
Meijer, G.A.3
Tuk, C.W.4
van Garderen, E.5
van Rooijen, N.6
-
41
-
-
0347123433
-
Tumour-educated macrophages promote tumour progression and metastasis
-
10.1038/nrc1256, 14708027
-
Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004, 4(1):71-8. 10.1038/nrc1256, 14708027.
-
(2004)
Nat Rev Cancer
, vol.4
, Issue.1
, pp. 71-78
-
-
Pollard, J.W.1
-
42
-
-
0035863471
-
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity
-
Mitsiades N, Yu WH, Poulaki V, Tsokos M, Stamenkovic I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 2001, 61(2):577-81.
-
(2001)
Cancer Res
, vol.61
, Issue.2
, pp. 577-581
-
-
Mitsiades, N.1
Yu, W.H.2
Poulaki, V.3
Tsokos, M.4
Stamenkovic, I.5
-
43
-
-
0035216956
-
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
-
10.1038/sj.neo.7900190, 1506562, 11774028
-
Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 2001, 3(6):459-68. 10.1038/sj.neo.7900190, 1506562, 11774028.
-
(2001)
Neoplasia
, vol.3
, Issue.6
, pp. 459-468
-
-
Fingleton, B.1
Vargo-Gogola, T.2
Crawford, H.C.3
Matrisian, L.M.4
-
44
-
-
0030850621
-
Angiogenesis and inflammation in invasive carcinoma of the breast
-
10.1136/jcp.50.8.669, 500114, 9301551
-
Lee AH, Happerfield LC, Bobrow LG, Millis RR. Angiogenesis and inflammation in invasive carcinoma of the breast. J Clin Pathol 1997, 50(8):669-73. 10.1136/jcp.50.8.669, 500114, 9301551.
-
(1997)
J Clin Pathol
, vol.50
, Issue.8
, pp. 669-673
-
-
Lee, A.H.1
Happerfield, L.C.2
Bobrow, L.G.3
Millis, R.R.4
-
45
-
-
0029884643
-
Bisphosphonates: mechanisms of action
-
10.1172/JCI118722, 507360, 8675678
-
Rodan GA, Fleisch HA. Bisphosphonates: mechanisms of action. J Clin Invest 1996, 97(12):2692-6. 10.1172/JCI118722, 507360, 8675678.
-
(1996)
J Clin Invest
, vol.97
, Issue.12
, pp. 2692-2696
-
-
Rodan, G.A.1
Fleisch, H.A.2
-
46
-
-
34648828862
-
Bisphosphonates in cancer therapy
-
10.1016/j.canlet.2007.07.007, 17697748
-
Stresing V, Daubiné F, Benzaid I, Mönkkönen H, Clézardin P. Bisphosphonates in cancer therapy. Cancer Letters 2007, 257(1):16-35. 10.1016/j.canlet.2007.07.007, 17697748.
-
(2007)
Cancer Letters
, vol.257
, Issue.1
, pp. 16-35
-
-
Stresing, V.1
Daubiné, F.2
Benzaid, I.3
Mönkkönen, H.4
Clézardin, P.5
-
47
-
-
73849142181
-
Bisphosphonates in breast cancer: teaching an old dog new tricks
-
10.1097/CCO.0b013e328331c794, 19730102
-
Winter MC, Coleman RE. Bisphosphonates in breast cancer: teaching an old dog new tricks. Curr Opin Oncol 2009, 21(6):499-506. 10.1097/CCO.0b013e328331c794, 19730102.
-
(2009)
Curr Opin Oncol
, vol.21
, Issue.6
, pp. 499-506
-
-
Winter, M.C.1
Coleman, R.E.2
-
48
-
-
34547862034
-
Antiresorptive agents and osteoclast apoptosis
-
10.1002/jcb.21311, 17407157
-
Stern PH. Antiresorptive agents and osteoclast apoptosis. Journal of Cellular Biochemistry 2007, 101(5):1087-96. 10.1002/jcb.21311, 17407157.
-
(2007)
Journal of Cellular Biochemistry
, vol.101
, Issue.5
, pp. 1087-1096
-
-
Stern, P.H.1
-
49
-
-
33846628622
-
Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro
-
10.1016/j.bcp.2006.09.031, 17157266
-
Moreau MF, Guillet C, Massin P, Chevalier S, Gascan H, Baslé MF, et al. Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochemical Pharmacology 2007, 73(5):718-23. 10.1016/j.bcp.2006.09.031, 17157266.
-
(2007)
Biochemical Pharmacology
, vol.73
, Issue.5
, pp. 718-723
-
-
Moreau, M.F.1
Guillet, C.2
Massin, P.3
Chevalier, S.4
Gascan, H.5
Baslé, M.F.6
-
50
-
-
81255153229
-
Nitrogen-Containing Biphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins
-
Luckman SP, Hughes DE, Coxon FP, Russell RGG, Rogers MJ. Nitrogen-Containing Biphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins. Including Ras. 13 1998, 11(4).
-
(1998)
Including Ras. 13
, vol.11
, Issue.4
-
-
Luckman, S.P.1
Hughes, D.E.2
Coxon, F.P.3
Russell, R.G.G.4
Rogers, M.J.5
-
51
-
-
33644539542
-
A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates
-
10.1038/sj.bjp.0706628, 1616989, 16402039
-
Mönkkönen H, Auriola S, Lehenkari P, Kellinsalmi M, Hassinen IE, Vepsäläinen J, et al. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates. British Journal of Pharmacology 2006, 147:437-45. 10.1038/sj.bjp.0706628, 1616989, 16402039.
-
(2006)
British Journal of Pharmacology
, vol.147
, pp. 437-445
-
-
Mönkkönen, H.1
Auriola, S.2
Lehenkari, P.3
Kellinsalmi, M.4
Hassinen, I.E.5
Vepsäläinen, J.6
-
52
-
-
0036856052
-
Bisphosphonates in cancer therapy
-
10.1097/00001622-200211000-00004, 12409650
-
Green JR. Bisphosphonates in cancer therapy. Current Opinion in Oncology 2002, 14(6):609-15. 10.1097/00001622-200211000-00004, 12409650.
-
(2002)
Current Opinion in Oncology
, vol.14
, Issue.6
, pp. 609-615
-
-
Green, J.R.1
-
53
-
-
0035146537
-
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates
-
Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 2001, 296(2):235-42.
-
(2001)
J Pharmacol Exp Ther
, vol.296
, Issue.2
, pp. 235-242
-
-
Dunford, J.E.1
Thompson, K.2
Coxon, F.P.3
Luckman, S.P.4
Hahn, F.M.5
Poulter, C.D.6
-
54
-
-
77952720882
-
Bisphosphonates in the treatment of metabolic bone diseases
-
10.1590/S0004-27302010000200017, 20485910
-
Arantes HP, Silva AG, Lazaretti-Castro M. Bisphosphonates in the treatment of metabolic bone diseases. Arq Bras Endocrinol Metabol 2010, 54(2):206-12. 10.1590/S0004-27302010000200017, 20485910.
-
(2010)
Arq Bras Endocrinol Metabol
, vol.54
, Issue.2
, pp. 206-212
-
-
Arantes, H.P.1
Silva, A.G.2
Lazaretti-Castro, M.3
-
55
-
-
36549010158
-
Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates
-
10.1177/154405910708601102, 17959891
-
Kimmel DB. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res 2007, 86(11):1022-33. 10.1177/154405910708601102, 17959891.
-
(2007)
J Dent Res
, vol.86
, Issue.11
, pp. 1022-1033
-
-
Kimmel, D.B.1
-
56
-
-
0034659773
-
Cellular and molecular mechanisms of action of bisphosphonates
-
Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 2000, 88(12 Suppl):2961-78.
-
(2000)
Cancer
, vol.88
, Issue.12 SUPPL
, pp. 2961-2978
-
-
Rogers, M.J.1
Gordon, S.2
Benford, H.L.3
Coxon, F.P.4
Luckman, S.P.5
Monkkonen, J.6
-
57
-
-
0033065233
-
Bisphosphonates: from the laboratory to the clinic and back again
-
10.1016/S8756-3282(99)00116-7, 10423031
-
Russell RG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999, 25(1):97-106. 10.1016/S8756-3282(99)00116-7, 10423031.
-
(1999)
Bone
, vol.25
, Issue.1
, pp. 97-106
-
-
Russell, R.G.1
Rogers, M.J.2
-
58
-
-
39049153469
-
Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?
-
10.2174/157489206778776989, 18221048
-
Santini D, Schiavon G, Angeletti S, Vincenzi B, Gasparro S, Grilli C, et al. Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?. Recent Pat Anticancer Drug Discov 2006, 1(3):383-96. 10.2174/157489206778776989, 18221048.
-
(2006)
Recent Pat Anticancer Drug Discov
, vol.1
, Issue.3
, pp. 383-396
-
-
Santini, D.1
Schiavon, G.2
Angeletti, S.3
Vincenzi, B.4
Gasparro, S.5
Grilli, C.6
-
59
-
-
0036675220
-
Metastasis to bone: causes, consequences and therapeutic opportunities
-
10.1038/nrc867, 12154351
-
Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002, 2(8):584-93. 10.1038/nrc867, 12154351.
-
(2002)
Nat Rev Cancer
, vol.2
, Issue.8
, pp. 584-593
-
-
Mundy, G.R.1
-
60
-
-
0030826872
-
Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices
-
Boissier S, Magnetto S, Frappart L, Cuzin B, Ebetino FH, Delmas PD, et al. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Res 1997, 57(18):3890-4.
-
(1997)
Cancer Res
, vol.57
, Issue.18
, pp. 3890-3894
-
-
Boissier, S.1
Magnetto, S.2
Frappart, L.3
Cuzin, B.4
Ebetino, F.H.5
Delmas, P.D.6
-
61
-
-
0029916052
-
Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro
-
10.1172/JCI118841, 507479, 8698861
-
Van der Pluijm G, Vloedgraven H, van Beek E, van der Wee-Pals L, Lowik C, Papapoulos S. Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. J Clin Invest 1996, 98(3):698-705. 10.1172/JCI118841, 507479, 8698861.
-
(1996)
J Clin Invest
, vol.98
, Issue.3
, pp. 698-705
-
-
Van der Pluijm, G.1
Vloedgraven, H.2
van Beek, E.3
van der Wee-Pals, L.4
Lowik, C.5
Papapoulos, S.6
-
62
-
-
0034214362
-
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases
-
Boissier S, Ferreras M, Peyruchaud O, Magnetto S, Ebetino FH, Colombel M, et al. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res 2000, 60(11):2949-54.
-
(2000)
Cancer Res
, vol.60
, Issue.11
, pp. 2949-2954
-
-
Boissier, S.1
Ferreras, M.2
Peyruchaud, O.3
Magnetto, S.4
Ebetino, F.H.5
Colombel, M.6
-
63
-
-
3042729728
-
Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model
-
10.1158/1078-0432.CCR-03-0325, 15240548
-
Hiraga T, Williams PJ, Ueda A, Tamura D, Yoneda T. Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin Cancer Res 2004, 10(13):4559-67. 10.1158/1078-0432.CCR-03-0325, 15240548.
-
(2004)
Clin Cancer Res
, vol.10
, Issue.13
, pp. 4559-4567
-
-
Hiraga, T.1
Williams, P.J.2
Ueda, A.3
Tamura, D.4
Yoneda, T.5
-
64
-
-
0033783227
-
Bisphosphonates induce breast cancer cell death in vitro
-
10.1359/jbmr.2000.15.11.2211, 11092402
-
Fromigue O, Lagneaux L, Body JJ. Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res 2000, 15(11):2211-21. 10.1359/jbmr.2000.15.11.2211, 11092402.
-
(2000)
J Bone Miner Res
, vol.15
, Issue.11
, pp. 2211-2221
-
-
Fromigue, O.1
Lagneaux, L.2
Body, J.J.3
-
65
-
-
0034107048
-
Bisphosphonates induce apoptosis in human breast cancer cell lines
-
2363380, 10780527
-
Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW. Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer 2000, 82(8):1459-68. 2363380, 10780527.
-
(2000)
Br J Cancer
, vol.82
, Issue.8
, pp. 1459-1468
-
-
Senaratne, S.G.1
Pirianov, G.2
Mansi, J.L.3
Arnett, T.R.4
Colston, K.W.5
-
66
-
-
0037029682
-
The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells
-
10.1038/sj.bjc.6600297, 2375368, 11986784
-
Senaratne SG, Mansi JL, Colston KW. The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells. Br J Cancer 2002, 86(9):1479-86. 10.1038/sj.bjc.6600297, 2375368, 11986784.
-
(2002)
Br J Cancer
, vol.86
, Issue.9
, pp. 1479-1486
-
-
Senaratne, S.G.1
Mansi, J.L.2
Colston, K.W.3
-
67
-
-
33645814413
-
Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis
-
10.1124/mol.105.020776, 16501031
-
Thompson K, Rogers MJ, Coxon FP, Crockett JC. Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Mol Pharmacol 2006, 69(5):1624-32. 10.1124/mol.105.020776, 16501031.
-
(2006)
Mol Pharmacol
, vol.69
, Issue.5
, pp. 1624-1632
-
-
Thompson, K.1
Rogers, M.J.2
Coxon, F.P.3
Crockett, J.C.4
-
68
-
-
0029766224
-
Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism
-
Rogers MJ, Chilton KM, Coxon FP, Lawry J, Smith MO, Suri S, et al. Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism. Journal of Bone and Mineral Research 1996, 11(10):1482-91.
-
(1996)
Journal of Bone and Mineral Research
, vol.11
, Issue.10
, pp. 1482-1491
-
-
Rogers, M.J.1
Chilton, K.M.2
Coxon, F.P.3
Lawry, J.4
Smith, M.O.5
Suri, S.6
-
69
-
-
0023318392
-
Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages
-
Cecchini MG, Felix R, Fleisch H, Cooper PH. Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages. Journal of Bone and Mineral Research 1987, 2(2):135-42.
-
(1987)
Journal of Bone and Mineral Research
, vol.2
, Issue.2
, pp. 135-142
-
-
Cecchini, M.G.1
Felix, R.2
Fleisch, H.3
Cooper, P.H.4
-
70
-
-
0025175649
-
Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage
-
Cecchini MG, Fleisch H. Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage. Journal of Bone and Mineral Research 1990, 5(10):1019-27.
-
(1990)
Journal of Bone and Mineral Research
, vol.5
, Issue.10
, pp. 1019-1027
-
-
Cecchini, M.G.1
Fleisch, H.2
-
71
-
-
0043282662
-
Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates
-
10.1016/S0024-3205(03)00657-X, 12954450
-
Valleala H, Hanemaaijer R, Mandelin J, Salminen A, Teronen O, Mönkkönen J, et al. Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates. Life Sciences 2003, 73(19):2413-20. 10.1016/S0024-3205(03)00657-X, 12954450.
-
(2003)
Life Sciences
, vol.73
, Issue.19
, pp. 2413-2420
-
-
Valleala, H.1
Hanemaaijer, R.2
Mandelin, J.3
Salminen, A.4
Teronen, O.5
Mönkkönen, J.6
-
72
-
-
4944239035
-
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis
-
514591, 15343380
-
Giraudo E, Inoue M, Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 2004, 114(5):623-33. 514591, 15343380.
-
(2004)
J Clin Invest
, vol.114
, Issue.5
, pp. 623-633
-
-
Giraudo, E.1
Inoue, M.2
Hanahan, D.3
-
73
-
-
0031754521
-
Heterocycle-Containing Bisphosphonates Cause Apoptosis and Inhibit Bone Resorption by Preventing Protein Prenylation: Evidence from Structure-Activity Relationships in J774 Macrophages
-
10.1359/jbmr.1998.13.11.1668, 9797474
-
Luckman SP, Coxon FP, Ebetino FH, Russell RGG, Rogers MJ. Heterocycle-Containing Bisphosphonates Cause Apoptosis and Inhibit Bone Resorption by Preventing Protein Prenylation: Evidence from Structure-Activity Relationships in J774 Macrophages. Journal of Bone and Mineral Research 1998, 13(11):1668-78. 10.1359/jbmr.1998.13.11.1668, 9797474.
-
(1998)
Journal of Bone and Mineral Research
, vol.13
, Issue.11
, pp. 1668-1678
-
-
Luckman, S.P.1
Coxon, F.P.2
Ebetino, F.H.3
Russell, R.G.G.4
Rogers, M.J.5
-
74
-
-
0035104119
-
LPS induction of gene expression in human monocytes
-
10.1016/S0898-6568(00)00149-2, 11257452
-
Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001, 13(2):85-94. 10.1016/S0898-6568(00)00149-2, 11257452.
-
(2001)
Cell Signal
, vol.13
, Issue.2
, pp. 85-94
-
-
Guha, M.1
Mackman, N.2
-
75
-
-
77955771348
-
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells
-
10.1007/s10549-009-0622-8, 20711669
-
Morales JK, Kmieciak M, Knutson KL, Bear HD, Manjili MH. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res Treat 2010, 123(1):39-49. 10.1007/s10549-009-0622-8, 20711669.
-
(2010)
Breast Cancer Res Treat
, vol.123
, Issue.1
, pp. 39-49
-
-
Morales, J.K.1
Kmieciak, M.2
Knutson, K.L.3
Bear, H.D.4
Manjili, M.H.5
-
76
-
-
41149119143
-
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
-
10.1111/j.1600-065X.2008.00602.x, 18364001
-
Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008, 222:162-79. 10.1111/j.1600-065X.2008.00602.x, 18364001.
-
(2008)
Immunol Rev
, vol.222
, pp. 162-179
-
-
Marigo, I.1
Dolcetti, L.2
Serafini, P.3
Zanovello, P.4
Bronte, V.5
-
77
-
-
61349100687
-
Myeloid-derived suppressor cells as regulators of the immune system
-
10.1038/nri2506, 2828349, 19197294
-
Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9(3):162-74. 10.1038/nri2506, 2828349, 19197294.
-
(2009)
Nat Rev Immunol
, vol.9
, Issue.3
, pp. 162-174
-
-
Gabrilovich, D.I.1
Nagaraj, S.2
-
78
-
-
48149105507
-
Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages
-
10.1007/s00262-008-0482-9, 18297280
-
Tsagozis P, Eriksson F, Pisa P. Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages. Cancer Immunol Immunother 2008, 57(10):1451-9. 10.1007/s00262-008-0482-9, 18297280.
-
(2008)
Cancer Immunol Immunother
, vol.57
, Issue.10
, pp. 1451-1459
-
-
Tsagozis, P.1
Eriksson, F.2
Pisa, P.3
-
79
-
-
0036093899
-
Pamidronate induces modifications of circulating angiogenetic factors in cancer patients
-
Santini D, Vincenzi B, Avvisati G, Dicuonzo G, Battistoni F, Gavasci M, et al. Pamidronate induces modifications of circulating angiogenetic factors in cancer patients. Clin Cancer Res 2002, 8(5):1080-4.
-
(2002)
Clin Cancer Res
, vol.8
, Issue.5
, pp. 1080-1084
-
-
Santini, D.1
Vincenzi, B.2
Avvisati, G.3
Dicuonzo, G.4
Battistoni, F.5
Gavasci, M.6
-
80
-
-
10744227993
-
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients
-
Santini D, Vincenzi B, Dicuonzo G, Avvisati G, Massacesi C, Battistoni F, et al. Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res 2003, 9(8):2893-7.
-
(2003)
Clin Cancer Res
, vol.9
, Issue.8
, pp. 2893-2897
-
-
Santini, D.1
Vincenzi, B.2
Dicuonzo, G.3
Avvisati, G.4
Massacesi, C.5
Battistoni, F.6
-
81
-
-
20144381765
-
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients
-
10.1089/jir.2005.25.144, 15767788
-
Vincenzi B, Santini D, Dicuonzo G, Battistoni F, Gavasci M, La Cesa A, et al. Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients. J Interferon Cytokine Res 2005, 25(3):144-51. 10.1089/jir.2005.25.144, 15767788.
-
(2005)
J Interferon Cytokine Res
, vol.25
, Issue.3
, pp. 144-151
-
-
Vincenzi, B.1
Santini, D.2
Dicuonzo, G.3
Battistoni, F.4
Gavasci, M.5
La Cesa, A.6
-
82
-
-
34547653957
-
Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients
-
Santini D, Vincenzi B, Galluzzo S, Battistoni F, Rocci L, Venditti O, et al. Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients. Clin Cancer Res 2007, 13(15 Pt 1):4482-6.
-
(2007)
Clin Cancer Res
, vol.13
, Issue.15 PART 1
, pp. 4482-4486
-
-
Santini, D.1
Vincenzi, B.2
Galluzzo, S.3
Battistoni, F.4
Rocci, L.5
Venditti, O.6
-
83
-
-
78650051896
-
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
-
10.1111/j.1582-4934.2009.00926.x, 19818098
-
Coscia M, Quaglino E, Iezzi M, Curcio C, Pantaleoni F, Riganti C, et al. Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. J Cell Mol Med 2010, 14(12):2803-15. 10.1111/j.1582-4934.2009.00926.x, 19818098.
-
(2010)
J Cell Mol Med
, vol.14
, Issue.12
, pp. 2803-2815
-
-
Coscia, M.1
Quaglino, E.2
Iezzi, M.3
Curcio, C.4
Pantaleoni, F.5
Riganti, C.6
-
84
-
-
0036839143
-
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
-
Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol England 2002, 23(11):549-55.
-
(2002)
Trends Immunol England
, vol.23
, Issue.11
, pp. 549-555
-
-
Mantovani, A.1
Sozzani, S.2
Locati, M.3
Allavena, P.4
Sica, A.5
-
85
-
-
49749146393
-
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages
-
10.1111/j.1349-7006.2008.00880.x, 18754872
-
Hiraoka K, Zenmyo M, Watari K, Iguchi H, Fotovati A, Kimura YN, et al. Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages. Cancer Sci 2008, 99(8):1595-602. 10.1111/j.1349-7006.2008.00880.x, 18754872.
-
(2008)
Cancer Sci
, vol.99
, Issue.8
, pp. 1595-1602
-
-
Hiraoka, K.1
Zenmyo, M.2
Watari, K.3
Iguchi, H.4
Fotovati, A.5
Kimura, Y.N.6
-
86
-
-
34447556692
-
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
-
10.1038/sj.jid.5700827, 17460736
-
Gazzaniga S, Bravo AI, Guglielmotti A, van Rooijen N, Maschi F, Vecchi A, et al. Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol 2007, 127(8):2031-41. 10.1038/sj.jid.5700827, 17460736.
-
(2007)
J Invest Dermatol
, vol.127
, Issue.8
, pp. 2031-2041
-
-
Gazzaniga, S.1
Bravo, A.I.2
Guglielmotti, A.3
van Rooijen, N.4
Maschi, F.5
Vecchi, A.6
-
87
-
-
33746926292
-
Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach
-
10.1038/sj.bjc.6603240, 2360657, 16832418
-
Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, Schwendener RA. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 2006, 95(3):272-81. 10.1038/sj.bjc.6603240, 2360657, 16832418.
-
(2006)
Br J Cancer
, vol.95
, Issue.3
, pp. 272-281
-
-
Zeisberger, S.M.1
Odermatt, B.2
Marty, C.3
Zehnder-Fjallman, A.H.4
Ballmer-Hofer, K.5
Schwendener, R.A.6
-
88
-
-
77954229219
-
Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects
-
10.1158/1078-0432.CCR-09-2904, 20570927
-
Zhang W, Zhu XD, Sun HC, Xiong YQ, Zhuang PY, Xu HX, et al. Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clin Cancer Res 2010, 16(13):3420-30. 10.1158/1078-0432.CCR-09-2904, 20570927.
-
(2010)
Clin Cancer Res
, vol.16
, Issue.13
, pp. 3420-3430
-
-
Zhang, W.1
Zhu, X.D.2
Sun, H.C.3
Xiong, Y.Q.4
Zhuang, P.Y.5
Xu, H.X.6
-
89
-
-
77955982989
-
Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
-
10.1038/sj.bjc.6605814, 2938257, 20664588
-
Veltman JD, Lambers ME, van Nimwegen M, Hendriks RW, Hoogsteden HC, Hegmans JP, et al. Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma. Br J Cancer 2010, 103(5):629-41. 10.1038/sj.bjc.6605814, 2938257, 20664588.
-
(2010)
Br J Cancer
, vol.103
, Issue.5
, pp. 629-641
-
-
Veltman, J.D.1
Lambers, M.E.2
van Nimwegen, M.3
Hendriks, R.W.4
Hoogsteden, H.C.5
Hegmans, J.P.6
-
90
-
-
72849142082
-
Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects
-
10.2174/156800909789760285, 20025567
-
Marra M, Abbruzzese A, Addeo R, Del Prete S, Tassone P, Tonini G, et al. Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects. Curr Cancer Drug Targets 2009, 9(7):791-800. 10.2174/156800909789760285, 20025567.
-
(2009)
Curr Cancer Drug Targets
, vol.9
, Issue.7
, pp. 791-800
-
-
Marra, M.1
Abbruzzese, A.2
Addeo, R.3
Del Prete, S.4
Tassone, P.5
Tonini, G.6
-
91
-
-
81255153226
-
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study
-
Marra M, Salzano G, Leonetti C, Porru M, Franco R, Zappavigna S, et al. New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. Biotechnol Adv 2011,
-
(2011)
Biotechnol Adv
-
-
Marra, M.1
Salzano, G.2
Leonetti, C.3
Porru, M.4
Franco, R.5
Zappavigna, S.6
-
92
-
-
78650180151
-
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors
-
10.1016/j.ijpharm.2010.10.046, 21055454
-
Salzano G, Marra M, Porru M, Zappavigna S, Abbruzzese A, La Rotonda MI, et al. Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. Int J Pharm 2011, 403(1-2):292-7. 10.1016/j.ijpharm.2010.10.046, 21055454.
-
(2011)
Int J Pharm
, vol.403
, Issue.1-2
, pp. 292-297
-
-
Salzano, G.1
Marra, M.2
Porru, M.3
Zappavigna, S.4
Abbruzzese, A.5
La Rotonda, M.I.6
-
93
-
-
82255175215
-
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes
-
Marra M, Salzano G, Leonetti C, Tassone P, Scarsella M, Zappavigna S, et al. Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. Nanomedicine 2011,
-
(2011)
Nanomedicine
-
-
Marra, M.1
Salzano, G.2
Leonetti, C.3
Tassone, P.4
Scarsella, M.5
Zappavigna, S.6
-
94
-
-
3042796964
-
Bisphosphonates: new therapeutic agents for the treatment of bone tumors
-
10.1016/j.molmed.2004.05.007, 15242682
-
Heymann D, Ory B, Gouin F, Green JR, Redini F. Bisphosphonates: new therapeutic agents for the treatment of bone tumors. Trends Mol Med 2004, 10(7):337-43. 10.1016/j.molmed.2004.05.007, 15242682.
-
(2004)
Trends Mol Med
, vol.10
, Issue.7
, pp. 337-343
-
-
Heymann, D.1
Ory, B.2
Gouin, F.3
Green, J.R.4
Redini, F.5
-
95
-
-
0034062815
-
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel
-
Hillner BE, Ingle JN, Berenson JR, Janjan NA, Albain KS, Lipton A, et al. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. J Clin Oncol 2000, 18(6):1378-91.
-
(2000)
J Clin Oncol
, vol.18
, Issue.6
, pp. 1378-1391
-
-
Hillner, B.E.1
Ingle, J.N.2
Berenson, J.R.3
Janjan, N.A.4
Albain, K.S.5
Lipton, A.6
-
96
-
-
0642342669
-
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer
-
10.1200/JCO.2003.08.017, 12963702
-
Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003, 21(21):4042-57. 10.1200/JCO.2003.08.017, 12963702.
-
(2003)
J Clin Oncol
, vol.21
, Issue.21
, pp. 4042-4057
-
-
Hillner, B.E.1
Ingle, J.N.2
Chlebowski, R.T.3
Gralow, J.4
Yee, G.C.5
Janjan, N.A.6
-
97
-
-
0037302856
-
Antagonistic Effects of Different Classes of Bisphosphonates in Osteoclasts and Macrophages In Vitro
-
10.1359/jbmr.2003.18.2.204, 12568397
-
Frith JC, Rogers MJ. Antagonistic Effects of Different Classes of Bisphosphonates in Osteoclasts and Macrophages In Vitro. J Bone Miner Res 2003, 18(2):204-12. 10.1359/jbmr.2003.18.2.204, 12568397.
-
(2003)
J Bone Miner Res
, vol.18
, Issue.2
, pp. 204-212
-
-
Frith, J.C.1
Rogers, M.J.2
-
98
-
-
0034748323
-
The cellular uptake and metabolism of clodronate in RAW 264 macrophages
-
10.1023/A:1013026313647, 11758762
-
Monkkonen H, Rogers MJ, Makkonen N, Niva S, Auriola S, Monkkonen J. The cellular uptake and metabolism of clodronate in RAW 264 macrophages. Pharm Res 2001, 18(11):1550-5. 10.1023/A:1013026313647, 11758762.
-
(2001)
Pharm Res
, vol.18
, Issue.11
, pp. 1550-1555
-
-
Monkkonen, H.1
Rogers, M.J.2
Makkonen, N.3
Niva, S.4
Auriola, S.5
Monkkonen, J.6
|